Deutsche Bank analyst Falko Friedrichs lowered the firm’s price target on Fresenius Medical (FMS) to EUR 48 from EUR 50 and keeps a Hold rating on the shares.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FMS:
- Hold Rating Maintained for Fresenius Medical Care Amidst Flat US Growth and Downward Financial Adjustments
- Fresenius Medical Care Reports Modest Growth in 2025 Earnings
- Fresenius Medical Care’s Earnings Call Highlights Growth Amid Challenges
- Fresenius Medical Care Restructures with New Value-Based Care Segment
- Fresenius Medical reports Q2 adjusted EPS EUR0.91 vs. EUR0.72 last year